Compare BridgeBio Pharma Inc (BBIO) vs SoundHound AI Inc (SOUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs SoundHound AI Inc — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while SoundHound AI Inc trades at $7.43 (market cap $3.29B). The key difference: BridgeBio Pharma Inc is far larger — about 5× SoundHound AI Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, SoundHound AI Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | SOUN | |
|---|---|---|
Market Cap | $16.36B | $3.29B |
Sector | Health | Technology |
52-Week High | $90.17 | $21.40 |
52-Week Low | $47.29 | $5.70 |
Enterprise Value | $18.14B | $3.09B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About SoundHound AI Inc
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →
